Navigation Links
Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
Date:2/23/2011

ive diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis has designed and executed a patent strategy that has provided the Company with strong and extensive protection for Isis' drugs as well as all aspects of antisense drug discovery, development and manufacturing.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis Pharmaceuticals and the discovery, development and potential of ISIS-CRPRx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a leading ... announced today the appointments of Andrew ("Andy") Arno and ... of Directors. With these additions, the Asterias Board of ... independent. Andy Arno , 55, has ... He is currently Managing Director of Emerging Growth Equities, ...
(Date:8/20/2014)... , Aug. 20, 2014 The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down meth offenders and make arrests. ... Kansas blocked the sale ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: The Impact of ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... 3590) is complex legislation that affects virtually every ... provisions are beginning to take effect now. IVD ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6
... Solutions, Inc. (Allscripts – NASDAQ: MDRX ) ... Paul M. Black, former Chief Operating Officer of Cerner ... Senior Vice President and Chief Legal Officer for the ... immediately.  Mr. Black will serve on the Board,s Compensation ...
... Hours, or even minutes, can mean the difference between life ... of Emergency Medical Services (EMS) Week from May ... about how quick recognition of stroke symptoms and timely response ... return to full health. Stroke is the ...
Cached Medicine Technology:Allscripts Adds Two Independent Directors to Board 2Allscripts Adds Two Independent Directors to Board 3Allscripts Adds Two Independent Directors to Board 4Allscripts Adds Two Independent Directors to Board 5"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 2"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 3"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 4"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 5
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, 2014 (HealthDay ... nearly 12 percent in the last decade, a new report ... teens using indoor tanning beds barely decreased. Both indoor tanning ... cancers, including deadly melanomas, the researchers noted. "Unfortunately, we ... reported wearing sunscreen, from 67.7 percent in 2001 to 56.1 ...
(Date:8/21/2014)... Orange, NJ. August 21, 2014. Researchers have published ... the outcomes of patients with motor complete spinal ... disparities in functioning at discharge and follow-up among ... ahead of print on August 2 by the ... (doi: 10.1016/j.apmr.2014.07.398). Findings included small but significant differences ...
(Date:8/21/2014)... 2014 CarePoint Health is proud ... Patel, MD, and Sujoy Menon, MD, have joined ... and Dr. Menon to the community. CarePoint Health’s ... imaging services to patients in Hudson County through ... Hospital and Hoboken University Medical Center. Our board ...
(Date:8/21/2014)... August 21, 2014 The Mount Sinai ... tool called RateMyHospital®, which captures real-time patient feedback and ... patient’s care. The tool, now available to admitted patients ... collects feedback regarding patient satisfaction using smartphones. , ... because it gives us the timely information we need ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Cannabis Network that a company located in Massachusetts has ... the only marijuana patient verification system in ... welcome this new entity to our growing and compassionate ... our belief that these claims are inaccurate. , ...
Breaking Medicine News(10 mins):Health News:Fewer U.S. Teens Using Sunscreen, Study Finds 2Health News:Researchers examine impact of race and ethnicity in motor complete spinal cord injury 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2
... TOWNSHIP, Mich., Jan. 27 Financing has become a,very popular ... decade.,But long after you have had your "nip and tuck", ... looking for ways to get out of debt, and at ... surgery. , Dr. Charles Mok ...
... system chosen needs to match needs, culture of staff , , ... hospital is, the lower its rate of patient deaths and ... also saves centers money, the researchers report. , Although there ... Herrick, senior fellow at the National Center for Policy Analysis ...
... for the prevention of coronary heart disease, with ... at highest risk (ie, those with established heart ... estimation models may not be accurately achieved in ... groups whose 10-year "short-term" estimated risk seems low. ...
... Participants Control Weight Permanently , MIDLAND, Mich., Jan. 27 ... term is the challenge. With this Health Enhancement Systems ... NutriSum: Healthy Weight for Life ( ... to gain control of their weight -- and improve their ...
... Create SolutionsPITTSBURGH, Jan. 27 To ... and consultants, HM Insurance Group, a Highmark company, ... product line, which features dedicated worksite sales specialists, ... and membership management in a highly coordinated approach ...
... One in eight physicians have been inactive in the ... and most states do not require them to undergo competency ... , Because of the lack of regulation, patient safety could ... of Michigan Child Health Evaluation and Research (CHEAR) Unit and ...
Cached Medicine News:Health News:Lay Away Plan for Cosmetic Surgery 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 3Health News:Assessing the real risk of heart disease in young people with low short-term risks 2Health News:Thousands Look Better, Feel Better, and Have More Energy Because of NutriSum 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 3Health News:Most inactive physicians retain licenses, return to practice without competency review 2
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
Williams Micro Discectomy Instruments are designed to be used in the microsurgical treatment of herniated disks....
... System offers strength and radiolucent capabilities ... anteater titanium microdiscectomy system for microscope-aided ... for less invasive procedures with reduced ... to provide low profile, unobstructed retraction ...
Poppen-Gelpi Laminectomy Retractor, self-retaining....
Medicine Products: